Dernières nouvelles pour Nichirei (OTC:NCHEY) Stock

Nichirei Corp is a Japanese packaged-food company. Its segments are: processed foods, marine products, meat and poultry products, logistics, real estate, and biosciences. The company divisions are: Nichirei Foods, Nichirei Fresh, Logistic Group, and Bioscience. The Nichirei Food segment offers frozen foods, acerola products, and retort-pouch foods, while Nichirei Fresh offers marine products such as shrimp, salmon, trout, crab, octopus, squid, and shellfish, along with meat and poultry products like chicken, pork, and beef. The Nichirei Logistics Group offers transportation, delivery, and regional storage network services. The Bioscience division develops products (for example, antibodies, solution concentrate) and services for medical, cosmetics, health, and biotech companies.

Nichirei Corp

Macro Economic Events

News

Politics

Global

Economics

General

Reuters Reports Japan Economy Minister Akazawa Reportedly Says Agreed To Accelerate Trade Talks With U.S. Ahead Of G7 Summit; Nothing Is Agreed Until Everything Is Agreed; Economic Security Cooperation Comes Up On Agenda Every Meeting; Rare Earth, Other Key Minerals Among Important Economic Security Topics; No Change In Stance That Tariffs, Including Those On Auto Parts, Regrettable; Aim To Complement U.S., Japan Strengths In Chips

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4439265-1&amp;h=850002258&amp;u=https%3A%2F%2Fwww.davita.com%2F&amp;a=DaVita">DaVita</a>, a comprehensive kidney care company, issued the following statement in response to&nbsp;updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek, chief transformation officer for DaVita.
"As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices (KCC) Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."

DaVita Supports One-Year Extension of Kidney Care Choices Model, Citing Long-Term Savings and Improved Patient Outcomes

WIIM

Major indexes are lower amid US-China trade uncertainty after President Trump on social media said China has violated its agreement and federal appeals court on Thursday temporarily reinstated most of the tariffs imposed by Trump. Additionally, the Trump administration reportedly plans tech sector restrictions.

<a href="https://www.semafor.com/article/05/30/2025/california-opens-inquiry-into-paramount-and-trump">https://www.semafor.com/article/05/30/2025/california-opens-inquiry-into-paramount-and-trump</a>

PARA

'California opens inquiry into Paramount and Trump'- Semafor

<a href="https://www.washingtonpost.com/health/2025/05/30/covid-vaccines-children-pregnant-women/" title="https://www.washingtonpost.com/health/2025/05/30/covid-vaccines-children-pregnant-women/">https://www.washingtonpost.com/health/2025/05/30/covid-vaccines-children-pregnant-women/</a>

Biotech

BNTX

MRNA

NVAX

'Contradicting RFK Jr., CDC keeps recommending covid vaccine for kids' - Washington Post

The iShares China Large-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NASDAQ">FXI</a>), which tracks the performance of 50 of the largest Chinese companies listed in Hong Kong, fell 1.91% to $34.94 on Friday afternoon, under pressure from renewed U.S.-China trade tensions and broad market weakness.
A federal appeals court <a href="https://www.benzinga.com/markets/market-summary/25/05/45689974/us-stocks-likely-to-open-lower-as-appeals-court-temporarily-reinstates-tariffs-the-market-hate-uncertainty-says-expert">temporarily reinstated</a> most of the recent tariffs imposed by President&nbsp;Donald Trump, pausing a lower court ruling that had invalidated them. The stay allows the administration to continue its appeal, further stoking U.S.-China trade tensions.
What To Know: Friday&#8217;s decline also comes as President Donald Trump <a href="https://www.benzinga.com/markets/equities/25/05/45701116/wall-street-slumps-as-trump-reignites-china-trade-tensions-nvidia-wipes-out-earnings-rally-whats-driving-markets-friday">accused</a> China of "totally" breaching a prior tariff agreement, sparking fresh fears of a trade war resurgence. Reports indicate the White House is preparing expanded tech sanctions, potentially targeting companies with indirect links to already-sanctioned entities.
These geopolitical jitters weighed heavily on global markets. The S&amp;P 500 lost 1% and the Nasdaq-100 dropped 1.3%, with only defensive sectors managing gains.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/05/45701546/whats-going-on-with-trump-media-shares-today">What&#8217;s Going On With Trump Media Shares Today?</a>
Economic data <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">added</a> to investor uncertainty. While the Fed's preferred inflation gauge, the core PCE index, cooled to 2.5% year-over-year in April, suggesting subdued price pressures, consumer spending growth slowed sharply to 0.2%, signaling softening demand. 
At the same time, consumer sentiment remained at a three-year low, and inflation expectations for the next year surged to 4.5%. FXI&#8217;s sharp drop Friday reflects investor anxiety over both external trade risks and internal U.S. economic fragility, as sentiment shifted away from risk assets heading into the weekend.
Read Also: <a href="https://www.benzinga.com/cannabis/25/05/45700679/rivian-rivn-stock-is-volatile-whats-going-on">Rivian Stock Is Volatile: What&#8217;s Going On?</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, FXI has a 52-week high of $38.73 and a 52-week low of $24.59.
Image: Shutterstock

iShares China Large-Cap ETF (FXI) Drops As Trade Tensions Resurface, Economic Data Sends Mixed Signals

When a 65-year-old woman named Dottie wrote in to Suze Orman's "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-will-i-really-be-able-to-retire">Women &amp; Money</a>" podcast, she was looking for reassurance about her retirement savings. What she got was much more: a strong reminder that financial success is about more than just the numbers in your bank account.
Here's what Dottie shared — and why Orman believes her situation is stronger than she thinks.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">A Snapshot of Dottie's Finances</h2>
Dottie described herself as a newly single 65-year-old woman in good health. She works part time and brings in about $3,000 a month from her job, along with $1,600 in <a href="https://www.benzinga.com/25/05/45521151/4000-senior-bonus-tax-break-proposed-but-critics-say-its-a-consolation-prize-for-broken-social-security-promises">Social Security</a>. She plans to continue working for another three to four years.
Her savings include:
<ul class="wp-block-list">
<li>$350,000 in certificates of deposit</li>
<li>$250,000 in an IRA</li>
</ul>
She owns her car outright, has no debt, and although she rents, her living expenses are low. She even makes sure to enjoy herself and spend on fun activities.
Her question for Orman was simple: "How far behind am I in retirement savings at this stage?"
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">Suze Orman: "You Are So Far Ahead"</h2>
Orman's response was immediate and enthusiastic.
"Oh, Dottie," she began, "it's not how far behind you are in retirement savings at this stage. It's how far behind you happen to be in comparing yourself to others."
<a href="https://www.benzinga.com/personal-finance/25/05/45587754/i-contributed-after-tax-amounts-to-a-pre-tax-ira-can-i-withdraw-those-contributions-to-open-a-roth-account-heres-what-suze-orman-says">Orman</a> explained that many people judge their financial situation by comparing it to others — those who appear wealthier or live more extravagantly. But appearances can be deceiving. Someone might own multiple homes and drive a luxury car, but still be drowning in debt.
"You, my dear, are so far ahead," Orman said. "You have no debt. You own your car outright. You have $250,000 in your IRA. You have $350,000 in CDs, and you're going to get Social Security. Are you kidding me? You are going to be just fine as long as your expenses are always less than the money that you have coming in."
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Why Debt — Not Income — Tells the Real Story</h2>
Throughout her career, Orman has emphasized a key lesson: your expenses matter more than your income. It's not about how much you earn or have saved — it's about what that money needs to cover.
To illustrate her point, Orman recalled her experience doing <a href="https://www.benzinga.com/25/05/45256709/approaching-retirement-suze-ormans-2025-plan-for-safe-high-earning-cash">retirement planning</a> for Pacific Gas and Electric employees. She noted that workers with modest pensions and small savings often fared better in retirement than high-earning executives with multiple homes, expensive cars, and constant financial pressure.
<h2 class="wp-block-heading">A Reminder for Anyone Nearing Retirement</h2>
For those approaching retirement, Orman's message is clear: don't measure your financial health against others. Instead, focus on your own expenses, your savings, and whether your income will reliably cover your needs.
"You are not behind," Orman told Dottie. "You are ahead of most everybody out there."
As long as Dottie keeps her expenses lower than her income — and continues to live within her means — Orman believes she's on track for a comfortable retirement.
Read Next:
<ul class="wp-block-list">
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Suze Orman Tells 65-Year-Old With $600K Savings And No Debt: 'You Are So Far Ahead'

<a href="https://www.benzinga.com/personal-finance/25/03/44438885/charlie-munger-told-a-20-year-old-that-getting-rich-through-investing-is-damn-near-impossible-and-you-might-need-10-million-in-the-bank">Charlie Munger</a> lived near Paramount Studios—and never once took the bait. While others got starstruck by Hollywood, he stayed unimpressed and uninvested. At the 2023 Daily Journal meeting, months before his passing, Munger didn't just dodge questions. He dropped truth bombs.
By then, he'd seen it all: the Great Depression, tech booms, dot-com busts, and Bitcoin hype. But nothing rattled him quite like showbiz.
So when CNBC's Becky Quick <a href="https://www.benzinga.com/personal-finance/25/04/44939515/charlie-munger-was-asked-if-disney-was-still-a-good-investment-they-once-owned-the-world-now-its-a-bloodbath-welcome-to-human-life">asked him about Disney</a>, she got the kind of answer only Munger could give.
"Practically every business that Disney has has gotten tougher than it used to be," he said. "Again, welcome to human life."
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
That's how he opened. No dramatic buildup. Just a clear, cold observation: nothing stays easy forever—not even for a company that once "owned the world," as Munger put it. He recalled Disney's era of dominance—"The Lion King" conquering Broadway, content triumphs stacking up, victory after victory.
"They went from triumph to triumph, marching, marching, marching," he said. "All of a sudden, on practically every front, it's more difficult. This is what happens."
Munger wasn't writing Disney off. He noted the company still had real assets. But he didn't sugarcoat what they're up against. "How would you like running the sports, ESPN, now at Disney compared to its heyday?" he asked. "It's going to be way harder for them."
Even the movie business, he warned, looked grim. "Movies look, to me, like it's going to be a bloodbath, too. It's not a bit easy."
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
That wasn't nostalgia talking. It was analysis. "In the heyday of ESPN, Disney made nothing but money out of ESPN. It was a total goldmine," he said.&nbsp;
When the conversation shifted to Paramount—a large Berkshire holding at the time—Munger distanced himself fast. "I live within a few blocks from Paramount Studios and I don't even know anybody at Paramount," he said. "I have avoided the movies like the plague as an investor all my life."
He was just getting started.
"I've never made an investment in the movie business in any way, shape, or form. It always gives me the willies," he said. Then came the Munger rundown: "I don't like the unions, I don't like the crazy agents, I don't like the goddamn crazy lawyers, I don't like the crazy movie stars."
Even after his passing, his instincts seemed to echo. At the 2024 Berkshire Hathaway shareholder meeting, <a href="https://www.cnbc.com/2024/05/04/buffett-says-berkshire-sold-its-entire-paramount-stake-we-lost-quite-a-bit-of-money.html">Warren Buffett revealed</a> he had finally pulled the plug on Paramount —and paid the price.
"I was 100% responsible for the Paramount decision," Buffett admitted. "It was 100% my decision, and we've sold it all and we lost quite a bit of money."
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
While Munger had taken a lifelong stance against Hollywood, Buffett took a position—then an exit.&nbsp;
For Munger, it wasn't just the numbers—it was the culture. "Everything about it is not my culture," he said. "I liked those old English actors when they came over. I grew up with them. But, basically, movies are not my scene, so I've avoided it."
He wasn't against performers or artists making a living. "It may be a very good place to make a living as an actor or a writer or a musician," he allowed. "But it's a hard place to make money if you're an investor."
Munger never had time for chaos, hype, or industries run on personalities and promises. He wanted a margin of safety, cash flow, and predictability—and for him, the movie business had none of it.
Even in his final year, he kept doing what made him a legend: stripping things down to what they really were—and walking away when they didn't make sense.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Charlie Munger Snubbed Paramount And Hollywood: 'I Don't Like The Unions, Agents, Lawyers, Or The Crazy Movie Stars —Always Gives Me The Willies'

Knowing what to do with a 401(k) after leaving a job can feel overwhelming — especially for younger workers planning long-term. That's why a listener named Robert reached out to Suze Orman's "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-will-i-really-be-able-to-retire">Women &amp; Money</a>" podcast for guidance on what to do with his Roth 401(k) if he ever leaves his company.
Robert, 38, said he's been with his employer for 12 years and doesn't plan to leave anytime soon. Still, he wondered if he ever leaves his job, should he eventually roll his money into a Roth IRA, move it into a new employer's Roth 401(k), or just leave it where it is?
Here's what Orman had to say — and the one move she advised him to avoid.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Suze Orman: Skip the Roth 401(k) at Your New Job</h2>
Orman didn't offer a one-size-fits-all answer but made it clear that one option was off the table.&nbsp;
"Should you roll the money into a Roth 401(k) at a new company? No," she said. Instead, she encouraged Robert to either leave the money in his current <a href="https://www.benzinga.com/personal-finance/25/04/44889415/90-of-plans-offer-it-but-only-20-use-it-suze-orman-says-this-401k-feature-is-being-ignored-at-your-own-risk">Roth 401(k)</a> or roll it into a Roth IRA, depending on what he feels most comfortable with at the time.
Her reasoning? Over time, Robert could accumulate a large balance in his 401(k), possibly a million dollars or more. Liquidating and transferring that amount later might feel daunting, especially if he's unfamiliar with investment options in the new plan.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">Comparing the Options: Stay Put or Roll Over?</h2>
If Robert leaves his job, he'll typically have four options: cash out, leave the money in his old plan, roll it into a Roth IRA, or roll it into a new employer's Roth 401(k). Orman ruled out that last option, so let's look closer at the two she suggested.
Leaving the Money in Your Roth 401(k)
If the current 401(k) plan offers low-cost investment options and solid performance, leaving the funds where they are could make sense. In her <a href="https://www.suzeorman.com/blog/Retirement-Account-Rollovers-What-to-Consider">blog</a>, Orman mentions that larger companies often negotiate lower fees — sometimes under 0.20% in expense ratios — which can help preserve returns over time.
The downside? You'll have to manage multiple accounts if you <a href="https://www.benzinga.com/personal-finance/25/03/44567830/suze-orman-warns-this-401k-mistake-when-switching-jobs-could-cost-you-300000">switch employers</a> later. That can make retirement planning more complex down the road.
Rolling Into a Roth IRA
The other path Orman supports is rolling the funds into a Roth IRA. This option can give you greater control over your investments and simplify your portfolio if you're managing several old accounts.&nbsp;
But beware: as a<a href="https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2022/06/small-differences-in-mutual-fund-fees-can-cut-billions-from-americans-retirement-savings"> Pew Research study</a> highlights, some IRA versions of the same funds found in a 401(k) can carry higher fees, which can cost investors thousands over time if not carefully managed.
To keep costs low, Orman recommends using discount brokerages and investing in low-cost index funds or ETFs.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">What to Watch Out For</h2>
While rolling over your 401(k) can streamline your retirement accounts, there are some pitfalls to avoid:
<ul class="wp-block-list">
<li>Indirect Rollovers: These involve receiving a check and reinvesting the money yourself within 60 days. If you miss the deadline, you may face taxes and penalties.</li>
<li>Higher Fees: Not all IRAs are created equal. Make sure to research expense ratios and investment options before making a move.</li>
<li>Losing Employer-Only Investment Options: Some 401(k) plans include investment choices you won't find in an IRA or new employer's plan.</li>
</ul>
<h2 class="wp-block-heading">The Bottom Line</h2>
For Robert — and anyone considering what to do with their Roth 401(k) — the best choice depends on comfort level, investment familiarity, and fees. Orman's guidance is clear: Avoid rolling it into a new employer's plan. Instead, evaluate whether to keep it where it is or roll it into a low-cost <a href="https://www.benzinga.com/personal-finance/25/04/44656837/build-your-retirement-portfolio-while-saving-for-emergencies-a-roth-ira-can-double-as-an-emergency-fund-is-that-true">Roth IRA</a> that gives you more control and flexibility.
As always, it pays to compare your options carefully before making a decision.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

38-Year-Old Asks Suze Orman Where To Move His Roth 401(k) — She Says Avoid This One Option

Rumors

Trading Ideas

TOST

Watching Toast; Hearing Investor Business Daily's SwingTrader Picks Stock

Shares of Newsmax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMAX#NYSE">NMAX</a>) are trading lower Friday after the company filed for the potential resale of up to 121 million shares of its <a href="https://www.benzinga.com/pressreleases/25/05/ac45455622/newsmax-announces-first-quarter-2025-financial-results">Class B common stock.</a>
What To Know: The resale filing triggered investor concerns about potential dilution, as the offering could significantly increase the available share count on the market. Although the shares are being registered for resale and not being issued directly by the company, such filings often pressure stock prices as they signal a higher supply of shares may be introduced.
The sharp decline came despite Newsmax also announcing a multi-year renewal agreement with Verizon Fios to continue distribution of its cable channel. While the Verizon deal helps secure continued visibility for Newsmax's programming across a key subscriber base in the Northeast and Mid-Atlantic regions, investors focused primarily on the implications of the share registration.
The stock&#8217;s drop reflects market reaction to the potential for dilution and a more cautious outlook on the company&#8217;s capital strategy.
NMAX Price Action: Newsmax shares were down 18.4% at $18.21 at the time of writing according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45701116/wall-street-slumps-as-trump-reignites-china-trade-tensions-nvidia-wipes-out-earnings-rally-whats-driving-markets-friday">Wall Street Slumps As Trump Reignites China Trade Tensions, Nvidia Wipes Out Earnings Rally: What&#8217;s Driving Markets Friday? </a></li>
</ul>
Image Via Shutterstock.

Movers

NMAX

Newsmax Shares Drop Sharply After Announcing Resale Filing For 121 Million Shares: What's Going On?

With earnings behind us for Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), the stock&#8217;s resistance now sits near $700 while support is down near $560.
The chart is telling me that a rotation into that support before the next move up could be ahead.&nbsp;
Here&#8217;s how I&#8217;d use options to trade that move. The best way to do this is with a put butterfly on META into the end of the summer. 
The long put butterfly is a combination of a long put spread and a short put spread. The overall position is ‘technically neutral.' But if we trade into support and remove the trade near the middle strike, we are essentially taking a stance that the chart should fade to support before its next rally. 
With META&#8217;s relative resistance zone sitting at around $700 and support near $560, the option chains are pricing in a move that is $111 from the current price. With this trade, we are well inside that range to collect profit:
<ul class="wp-block-list">
<li>Buy to open 1 META 19 Sept 590 puts </li>
<li>Sell to open 2 META 19 Sept 560 puts </li>
<li>Buy to open 1 META 19 Sept 530 puts </li>
</ul>
The cost of the trade as of this writing is $2.15, which represents the total risk for the position. 
The breakeven price of the stock at expiration on this trade is calculated by subtracting the debit paid less the $590 strike. $590 + $2.15 = $592.15. The maximum return is the distance between the $590 and $560 strikes less the cost of the debit = $30 &#8211; $2.15 = $27.85 (or $2,785).
There are two possible ways to leave this trade:
<ol class="wp-block-list">
<li>Hold the option until the strike tests $560 and leave the trade with whatever profits sit in the position. </li>
<li>Set an alert for your max loss – if the option erodes to less than 50% of its price. Sell the position if your risk thresholds are breached.</li>
</ol>
<h2 class="wp-block-heading">Wall Street Veteran Posts Every Trade Live</h2>
No after-the-fact claims. Matt Maley's Inner Circle members see every entry, exit, and adjustment in real time with exact prices. Last week, they watched multiple big winners unfold from start to finish. Join Matt's Inner Circle <a href="https://www.benzinga.com/premium/ideas/7-day-free-trial-matt-maley-inner-circle/?el=ResearchDaily&amp;utm_campaign=7daytrial&amp;utm_adType=sponsorad&amp;utm_ad=RD053125&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_medium=newsletter">HERE</a> &#8211; 7 Days Free
Editorial content from our expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Opinion

My Top META Trade After Earnings

Wells Fargo analyst Mohit Bansal downgrades Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) from Overweight to Equal-Weight and lowers the price target from $700 to $580.

Downgrades

Price Target

Analyst Ratings

REGN

Wells Fargo Downgrades Regeneron Pharmaceuticals to Equal-Weight, Lowers Price Target to $580

<a href="https://www.youtube.com/watch?v=bdx14Y22w90">https://www.youtube.com/watch?v=bdx14Y22w90</a>
&nbsp;

President Trump, Elon Musk Hold News Conference At White House; President Trump Says China Violated Deal, Will Speak To Xi, Hopefully Work It Out; Trump Says Close To Gaza Deal; Will Let You Know Today Or Tomorrow; Chance For Deal With Iran; Iran Deal Possible In Not Too Distant Future

Citigroup analyst James Hardiman maintains BRP (TSX:<a class="ticker" href="https://www.benzinga.com/stock/DOO#TSX">DOO</a>) with a Neutral and raises the price target from C$49 to C$60.

TSX:DOO

Citigroup Maintains Neutral on BRP, Raises Price Target to C$60

Goldman Sachs analyst David Roman initiates coverage on Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) with a Neutral rating and announces Price Target of $16.

Initiation

BBNX

Goldman Sachs Initiates Coverage On Beta Bionics with Neutral Rating, Announces Price Target of $16

Citigroup analyst Tyler Radke maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Buy and raises the price target from $265 to $329.

VEEV

Citigroup Maintains Buy on Veeva Systems, Raises Price Target to $329

Donaldson Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) today announced that its Board of Directors declared a regular cash dividend of 30.0 cents per share, an increase of 11.1% from the prior quarterly dividend of 27.0 cents per share. The dividend is payable June 30, 2025, to shareholders of record on June 16, 2025. Donaldson is a member of the S&amp;P High-Yield Dividend Aristocrats Index and calendar year 2024 marked the 29th consecutive year of annual dividend increases. The Company has paid a cash dividend every quarter for 69 years.

Dividends

Donaldson Company Increases Quarterly Cash Dividend From $0.27 To $0.30 Per Share

Tech giant NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a href="https://www.benzinga.com/general/social-media/24/03/37879478/humble-beginnings-like-nvidia-reddit-was-founded-inside-a-restaurant">was founded in a Denny's </a>restaurant by friends Jensen Huang, Chris Malachowsky and Curtis Priem.
Today, the company is worth more than 3 trillion and Huang is one of the richest people in the world.
What Happened: The connection between Denny's Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DENN#NASDAQ">DENN</a>) and Nvidia will remain a part of <a href="https://www.benzinga.com/general/entertainment/25/05/45482864/nvidias-jensen-huang-doesnt-want-you-to-order-a-shake-at-dennys-get-a-coke-he-says">the company's history, </a>with the company being founded at a restaurant location in California.
Huang also previously worked as a dishwasher, busboy and waiter at Denny's, with his LinkedIn <a href="https://www.linkedin.com/in/jenhsunhuang/">profile </a>famously listing his work experience at Denny's from 1978 to 1983 and his role as Founder and CEO of NVIDIA from 1993 to present.
While the two companies are historically connected, their stock performance over the last few decades is extremely different and disconnected.
Denny's stock, which went public in 1997, has fallen 45% in the last year, is down 64% over the last five years and is down over 50% since going public.
Nvidia stock, which<a href="https://www.benzinga.com/general/education/25/01/43140861/if-you-invested-1000-in-nvidia-stock-at-ipo-heres-how-much-youd-have-today-2"> went public in 1999</a>, is up 21% over the last year, up over 1,400% over the last five years and a top performer since going public with gains of over 334,000%.
With the increase in Nvidia's stock price, the wealth of Huang has also risen.
Today, the Nvidia CEO is the 12th richest person in the world worth $122 billion, as reported by <a href="https://www.bloomberg.com/billionaires/?sref=TBDibEcD">Bloomberg</a>. While Huang has a ways to go ($24 billion) to re-enter the top 10 list, he is worth significantly more than many people around the world and worth more than many companies.
In fact, Huang is now worth 604.9x Denny&#8217;s current market capitalization ($201.7 million), a multiple that could bring the connection between the two companies full circle.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45675006/nvidia-stock-has-significant-upside-as-ai-godfather-jensen-huang-delivers-another-robust-quarter">Nvidia Stock Has &#8216;Significant Upside&#8217; As AI &#8216;Godfather&#8217; Jensen Huang Delivers Another &#8216;Robust Quarter&#8217;</a>
Why It's Important: A company founded by friends inside a Denny's booth is now worth more than $3 trillion and the company's CEO is 604.9x richer than the value of the entire Denny's restaurant company.
Huang has often recalled the famous breakfast meeting with the other Nvidia co-founders that led to the company's creation.
&#8220;It had all the coffee you could drink and no one could chase you out,&#8221; Huang recalled of the Denny&#8217;s meeting.
The famous Denny&#8217;s location also paid tribute to its connections to the business launch, with a plaque unveiled in September 2023.
Huang&nbsp;<a href="https://blogs.nvidia.com/blog/nvidia-dennys-trillion/" target="_blank" rel="noreferrer noopener">visited&nbsp;</a>the Denny&#8217;s location in 2023 and recalled the famous meeting while speaking with Denny&#8217;s CEO&nbsp;Kelli Valade.
&#8220;Denny&#8217;s has taught me so many lessons,&#8221; Huang said.
The Nvidia co-founder recalled having his first job at a Denny&#8217;s in Portland when he was 15 years old.
&#8220;I was a dishwasher, I was a busboy, I waited tables. No one can carry more coffee cups than I can.&#8221;
Huang encouraged people to get their first job in the restaurant business.
&#8220;It teaches you humility, it teaches you hard work, it teaches you hospitality.&#8221;
The three co-founders dreamed up the idea of creating a chip that would help make 3D graphics realistic on personal computers.
The plaque reads &#8220;the booth that launched a $1 trillion company.&#8221;
A post on X<a href="https://www.benzinga.com/news/24/02/37299226/alexis-ohanian-says-jensen-huangs-trillion-dollar-nvidia-brainwave-at-dennys-is-better-than-his-bill" target="_blank" rel="noreferrer noopener">&nbsp;highlighted the connection&nbsp;</a>between Nvidia and Denny&#8217;s.
&#8220;Nvidia was founded during a breakfast meeting at Denny&#8217;s. Today, Nvidia makes more money in four hours than Denny&#8217;s makes in a year,&#8221; Jon Ehrlichman tweeted in February 2024.
<ul class="wp-block-list">
<li>You may not be a billionaire like Jensen Huang, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/trading-ideas/25/05/45600269/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-66">check out five stocks flying under the radar that deserve your attention.</a></li>
</ul>
Photo: jamesonwu1972 on Shutterstock.com

Education

DENN

NVDA

Jensen Huang Founded Nvidia At A Denny's, Now He's Worth 600x More Than The Restaurant Chain

Citigroup analyst Andrew Kaplowitz maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Neutral and raises the price target from $141 to $160.

Comments

Nichirei

Actualités

Dernières nouvelles pour Nichirei (OTC:NCHEY) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL